Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
31 results about "Removal tumor" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Contrast enhancing solution for use in confocal microscopy
InactiveUS7128894B1Improve featuresIncrease contrastIn-vivo testing preparationsRadiologyContrast enhancement
A method of optically detecting a tumor during surgery. The method includes imaging at least one test point defined on the tumor using a first optical imaging system to provide a first tumor image. The method further includes excising a first predetermined layer of the tumor for forming an in-vivo defect area. A predetermined contrast enhancing solution is disposed on the in-vivo defect area, which is adapted to interact with at least one cell anomaly, such as basal cell carcinoma, located on the in-vivo defect area for optically enhancing the cell anomaly. Thereafter the defect area can be optically imaged to provide a clear and bright representation of the cell anomaly to aid a surgeon while surgically removing the cell anomaly.
Owner:THE GENERAL HOSPITAL CORP
Surgical Instrument for Detecting, Isolating and Excising Tumors
A cutter (8) is telescopically received in a cannula (9) and both the cutter and cannula are telescopically mounted on a tubular carrier (7). A detection device (6) may be inserted through the open-ended carrier, cutter and cannula to properly place the surgical instrument in alignment with the tumor to be excised. Positioning tines (80) may penetrate the patient to firmly locate the carrier in its proper position on the patient. The cutter and cannula are moved about the carrier and are pressed into the tissue of the patient with the expectation that the circular core (60) of breast tissue formed by the cutter will have clear margins about the tumor. If the tumor extends too close to the circular incision, the cannula may be rotated so that its sidewall opening (26) faces the side of the remaining tissue to be excised and the surgeon can pull the remaining tissue through the sidewall and excise it, thereby avoiding a separate and delayed surgical procedure.
Owner:KENNEDY JOHN S
Surgical instrument for detecting, isolating and excising tumors
InactiveUS8128647B2Precise positioningCannulasDiagnosticsAbnormal tissue growthSurgical instrumentation
A cutter (8) is telescopically received in a cannula (9) and both the cutter and cannula are telescopically mounted on a tubular carrier (7). A detection device (6) may be inserted through the open-ended carrier, cutter and cannula to properly place the surgical instrument in alignment with the tumor to be excised. Positioning tines (80) may penetrate the patient to firmly locate the carrier in its proper position on the patient. The cutter and cannula are moved about the carrier and are pressed into the tissue of the patient with the expectation that the circular core (60) of breast tissue formed by the cutter will have clear margins about the tumor. If the tumor extends too close to the circular incision, the cannula may be rotated so that its sidewall opening (26) faces the side of the remaining tissue to be excised and the surgeon can pull the remaining tissue through the sidewall and excise it, thereby avoiding a separate and delayed surgical procedure.
Owner:KENNEDY JOHN S
Medicine carrying injectable implanted in-situ hydrogel
InactiveCN111228212AMild reaction conditionsSelf-healingOrganic active ingredientsAerosol deliveryRemoval tumorResidual Tumors
The invention discloses a medicine carrying injectable implanted in-situ hydrogel which is characterized by being formed at an injection part in situ on the basis of a Schiff base reaction in a chemical bond cross-linking mode, and the hydrogel has self adaptability to the shape of an injection cavity, and is long in retention time in the cavity, and medicines are in controlled release. The hydrogel is used for filling of cavities after a tumor operation, the cavities can be rapidly filled through flowability of the in-situ hydrogel, the hydrogel can be in close contact with edge tissue aftertumor excision, residual tumor cells can be well eliminated, and a remarkable effect of preventing tumor recurrence can be achieved.
Owner:ACADEMY OF MILITARY MEDICAL SCI
Methods of treating upper tract urothelial carcinomas
The invention relates to methods for locally delivering a chemotherapeutic agent to an upper tract urothelial carcinoma (UTUC). The methods involve placing a balloon catheter that has a working channel and a balloon into the ureter / renal pelvis via retrograde or antegrade ureteral access; inflating the catheter balloon to temporarily obstruct the ureter; infusing (instilling) a liposomal formulation that includes a chemotherapeutic agent into the working channel of the catheter; and allowing the infused liposomal formulation to dwell in the ureter and / or renal pelvis for a time sufficient to allow at least a portion of the liposomal formulation to adhere to the urothelial wall. In the methods of the invention, at least a portion of the infused chemotherapeutic-agent formulation adheres tothe urothelial wall while it is instilled and dwells in the ureter and / or renal pelvis. The disclosed methods can be performed as an adjuvant therapy to other methods of treating UTUC, such as ureteroscopic ablation or resection of the tumor.
Owner:WESTERN UNIV OF HEALTH SCI +1
Laparoscopic device for bloodless isolation, protection and excision of tumors
PendingCN110236643ATransfer protectionPrevent disseminationDiagnosticsExcision instrumentsRemoval tumorTumor vessel
The invention discloses a laparoscopic device for bloodless isolation, protection and excision of tumors. The device is characterized by being composed of a sealing push pipe, a guide supporting rod, an elastometric ring, a sealed sheath pipe protection bag and a base, wherein the sealing push pipe is of a hollow tubular structure, one end of the sealing push tube is provided with an internal opening, the pipe wall of the sealing push pipe is provided with leakage holes communicated with a pipe cavity, the other end of the sealing push pipe is provided with an external opening, an anti-air-leakage cap covers the external opening, and the pipe wall of the sealing push pipe is provided with an air inflation and deflation pipe and an air inflation and deflation switch; the guide supporting rod penetrates through the sealing push pipe, and one end of the guide supporting rod is connected with the elastometric ring; the elastometric ring is connected with a sealed sheath pipe protection bag mouth; a bag body is communicated with multiple sheath pipes, the sheath pipes are of tubular structures, the other ends of the sheath pipes are provided with threaded ports, and the threaded ports not only can be connected with a sealed cap, but also can be connected with the base; the base is internally provided with an unidirectional anti-air-leakage valve and a tee pipe. The device is used for laparoscopic tumor excision, not only blocks blood supply in tumor vessels, but also is isolated from other normal tissue organs in the abdominal cavity, and aims at preventing hemorrhage during operation and celiac implantation contamination by tumor cells.
Owner:合肥赫博医疗器械有限责任公司
Tumor enucleator and method of use
InactiveUS20200038042A1Vaccination/ovulation diagnosticsSurgical instrument detailsRemoval tumorEnergy source
An enucleator and method of use for resection of tumors, especially tumors of the bladder. The enucleator has a plurality of tentacles that are selective extensible and retractable from an elongate body. In a deployed, extended position, the tentacles may be positioned to surround the tumor and tumor stalk. The ends of the tentacles have a razor tipped edge that are oriented inwardly to surround. Utilizing the energy source at the tip of the razor ends, cut through the tumor stalk will finalize the enucleation en-bloc of the whole tumor in one piece.
Owner:AL SHRAIDEH YOUSEF SADEQ
Positioning device for assisting tumor excision
InactiveCN112057028ABasic visitationBasic flushing functionGastroscopesOesophagoscopesRemoval tumorEngineering
The invention relates to the technical field of oncology, in particular to a positioning device for assisting tumor excision, and overcomes the defects that the existing gastroscope is simple in structure and cannot position tumors. The positioning device comprises a lens and a stomach tube connected with the lens, wherein a probe, a water inlet and a water outlet are respectively mounted in the lens, a clamping motor is fixed in one side of the lens through bolts, a wire passing pipe is laid in the stomach tube, an opening is formed in one side of the lens, the lens is connected with a clamping rod connected with an output shaft of the clamping motor through an opening rotating shaft, the outer portions of the two ends of the clamping rod are sleeved with connecting blocks correspondingly, a horizontally-arranged transverse rod is welded to one side of the bottom of each connecting block, the transverse rod is sleeved with a supporting block and a first chuck, after the first chuck and a second chuck are conveniently driven to clamp and fix tumor soft tissue, transverse stripping can be conducted through the transverse rod, the chuck made of metal is left on a tumor, the positionof the tumor can be conveniently detected in real time through metal detection equipment, and the positioning effect is good.
Owner:常州市武进人民医院
Construction method and application of glioma cell line suitable for two-photon living imaging
PendingCN112300998ADynamic development monitoringAccurate inspection and trackingTumor/cancer cellsIn-vivo testing preparationsRemoval tumorCancer cell
The invention discloses a construction method of a glioma cell line suitable for two-photon living imaging. The construction method comprises the following steps: constructing a glioma cell in-situ transplantation animal model through glioma cells, and researching the dynamic development change of the glioma cells in the brain of a mouse by virtue of a two-photon living body imaging technology. The GL261-ZsGreen glioma cells obtained through transformation can be successfully used for constructing a glioma in-situ transplantation living animal model, the positions of tumor cells can be clearlyobserved in the imaging observation process, cell-level examination can be accurately performed when the GL261-ZsGreen glioma cells are applied to the research field, the glioma boundary can be obviously distinguished, and a potential means is provided for effectively and accurately excising tumors. Each proliferated GL261-ZsGreen cancer cell is provided with a green fluorescence label, so that single cancer cells subjected to dispersive metastasis can be accurately positioned, and a possible scheme is provided for further researching the diffusion of cancer cells and the accurate treatment of glioma.
Owner:LANZHOU UNIVERSITY
Postoperative recurrence risk assessment method and system for high-risk gastrointestinal stromal tumor patient
PendingCN112259231AObjective assessmentAccurate assessmentHealth-index calculationMedical automated diagnosisRemoval tumorTargeted therapy
The invention discloses a postoperative recurrence risk assessment method and system for a high-risk gastrointestinal stromal tumor patient. The method comprises the following steps: inputting original clinical data of preoperative hematological indexes and postoperative pathological indexes of a high-risk GIST patient; preprocessing the original clinical data, and calculating a preprocessing index; calculating a high-risk stromal tumor recurrence risk score according to original clinical data and the preprocessing index; and respectively carrying out qualitative and quantitative prediction scoring on a specific patient individual according to a high-risk stromal tumor recurrence risk scoring result, evaluating the prognosis and targeted therapy benefits of the patient after tumor excisionby an operation, and providing prediction and analysis results. The high-risk interstitial tumor recurrence risk score is calculated on the basis of the extracted indexes, experiments prove that thehigh-risk interstitial tumor recurrence risk score can objectively and accurately evaluate the recurrence risk of high-risk gastrointestinal interstitial tumor patients, and the defects of a traditional NIH grading system are overcome.
Owner:XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV
Tumor naked eye visible nanometer tracer agent and preparation method thereof
ActiveCN105412946ASmall particle sizeQuick resectionIn-vivo testing preparationsRemoval tumorOphthalmology
The invention provides a tumor naked eye visible nanometer tracer agent. The tumor naked eye visible nanometer tracer agent is prepared from 5-50 parts of soluble protein, 40-300 parts of lecithin and 5-50 parts of dye. The blue tumor naked eye visible nanometer tracer agent with the grain size smaller than or equal to 100 nm is prepared through ultrapure water dissolution and even mixing. The tumor naked eye visible nanometer tracer agent has biological compatibility and biodegradability and is safe and free of toxin for human bodies, and surgeons can distinguish tumor tissue and normal tissue through naked eyes under normal light rays without the help of additional instruments and accurately cut off tumors in surgery. A preparation method of the biodegradability is suitable for industrialized large-scale production.
Owner:NANNING KELUN NEW TECH CO LTD
Isolation device for preventing tumor cells from falling off under laparoscope
PendingCN111544102APrevent shedding plantingAccurate coating isolationSurgeryHuman bodyRemoval tumor
The invention provides an isolation device for preventing tumor cells from falling off under a laparoscope, which belongs to the technical field of laparoscopic surgery auxiliary devices and comprisesa tumor cell isolation bag, a glue spraying pipe and an injection device filled with biological albumen glue. The tumor cell isolation bag comprises a flexible fixing layer and a gauze layer; whereinthe flexible fixing layer is made of medical plastic or medical rubber, the edge of the flexible fixing layer is sewn or bonded with the gauze layer, the flexible fixing layer and the gauze layer define a biological albumen glue filling space, the shape of the flexible fixing layer and the shape of the gauze layer are matched with the shape of a tumor cell exposed surface, and the gauze layer isattached to the tumor cell exposed surface; the front end of the glue spraying pipe penetrates through the flexible fixing layer and extends into the bioprotein glue filling space, and the rear end ofthe glue spraying pipe is connected with a glue outlet of the injection device. The device can be placed in the abdominal cavity before tumor cells are excised, falling tumor cells or overflowing tumor cell contents are prevented from dispersing in the abdominal cavity, are isolated from a human body and are prevented from being in direct contact with normal human tissues and organs, so that theaim of preventive treatment is fulfilled.
Owner:山西省肿瘤医院
Catheter installation used for brain domain operation awaking anaesthesia
InactiveCN101310793BEasy to breatheMeet the requirements of precise positioningCatheterSleep inducing/ending devicesRemoval tumorTracheal tube
Owner:蔡铁良
Methods and panels of compounds for characterization of glioblastoma multiforme tumors and cancer stem cells thereof
ActiveUS20180252717A1Promote digestionOrganic active ingredientsMicrobiological testing/measurementAbnormal tissue growthGlioblastoma
A method of characterizing a glioblastoma multiforme (GBM) stem cell (GSC), comprising culturing the GSC to provide a culture, contacting a first set of aliquots of the culture with individual compounds selected from a panel of compounds, identifying two or more of the selected compounds that cause more than a threshold level of cell death in the first set of aliquots, and characterizing the GSC as suitable for treatment with one or more combinations comprising the two or more identified compounds. A panel of chemical compounds, the compounds selected by a method comprising surgically resecting the tumor, culturing a GSC derived from GBM tissue derived from a GBM tumor, contacting aliquots thereof with individual compounds selected from a panel of compounds, and identifying two or more of the selected compounds that cause more than a threshold level of cell death in the aliquots, thereby identifying the compounds.
Owner:SWEDISH HEALTH SERVICES
Methods of treating upper tract urothelial carcinomas
The invention relates to methods for locally delivering a chemotherapeutic agent to an upper tract urothelial carcinoma (UTUC). The methods involve placing a balloon catheter that has a working channel and a balloon into the ureter / renal pelvis via retrograde or antegrade ureteral access; inflating the catheter balloon to temporarily obstruct the ureter; infusing (instilling) a liposomal formulation that includes a chemotherapeutic agent into the working channel of the catheter; and allowing the infused liposomal formulation to dwell in the ureter and / or renal pelvis for a time sufficient to allow at least a portion of the liposomal formulation to adhere to the urothelial wall. In the methods of the invention, at least a portion of the infused chemotherapeutic-agent formulation adheres to the urothelial wall while it is instilled and dwells in the ureter and / or renal pelvis. The disclosed methods can be performed as an adjuvant therapy to other methods of treating UTUC, such as ureteroscopic ablation or resection of the tumor.
Owner:WESTERN UNIV OF HEALTH SCI +1
Robotic system for minimally invasive surgery
Systems and methods for performing minimally invasive surgical procedures, especially for removal of tumors, and especially for brain tumors, using a robotically inserted therapeutic probe, which first detects tumorous tissue on a pre-planned path through the patient's tissue, before performing therapeutic procedures on the tissue, such as ablation. This pre-treatment detection procedure is thus able to avoid the destruction of healthy tissue. This also ensures that the therapeutic process indicated in a preoperative surgical plan is only performed on tumorous tissue, without sole reliance onpreoperative image indications. This is important for neurosurgical operations performed on the brain, since preoperative images may not be accurate due to brain shift occurring during the procedure.Detection can be performed optically or ultrasonically, and treatment by laser or RF ablation. The probe insertion can be performed at 90 degrees to the insertion axis of the device, thus minimizing passage through healthy tissue.
Owner:TECHNION RES & DEV FOUND LTD
Positioning device for assisting tumor excision
InactiveCN114027766ABasic visitationBasic flushing functionGastroscopesOesophagoscopesRemoval tumorOncology
The invention relates to the technical field of oncology department, in particular to a positioning device for assisting in tumor excision. The positioning device overcomes the defects that an existing gastroscope is simple in structure and cannot position the tumor position. The positioning device comprises a lens and a stomach tube connected with the lens, a probe, a water inlet and a water outlet are separately mounted in the lens, a clamping motor is fixed in one side of the lens through a bolt, a wire passing tube is laid in the stomach tube, a notch is formed in one side of the lens, the lens is in rotating shaft connection with a clamping rod connected with an output shaft of the clamping motor, two ends of the clamping rod are each sleeved with a connecting block, and a horizontally-arranged transverse rod is welded to one side of the bottoms of the connecting blocks. A supporting block and a first clamping head are arranged in a sleeved mode through the transverse rod, after the first clamping head and a second clamping head are conveniently driven to clamp and fix tumor soft tissue, transverse stripping can be conducted through the transverse rod, the metal clamping heads are left on the tumor, the position of the tumor can be conveniently detected in real time through metal detection equipment, and the positioning effect is good.
Owner:常州市武进人民医院
Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes
PendingUS20220137066A1Avoid artifactsAvoid cross-reaction of the probes with each otherOrganic chemistryMicrobiological testing/measurementRemoval tumorMass spectrometry imaging
The field of this invention relates to immunohistochemistry (IHC) and in situ hybridization (ISH) for the targeted detection and mapping of biomolecules (e.g., proteins and miRNAs) in tissues or cells for example, for research use and for clinical use such by pathologists (e.g., biomarker analyses of a resected tumor or tumor biopsy). In particular, the use of mass spectrometric imaging (MSI) as a mode to detect and map the biomolecules in tissues or cells for example. More specifically, the field of this invention relates to photocleavable mass-tag reagents which are attached to probes such as antibodies and nucleic acids and used to achieve multiplex immunohistochemistry and in situ hybridization, with MSI as the mode of detection / readout. Probe types other than antibodies and nucleic acids are also covered in the field of invention, including but not limited to carbohydrate-binding proteins (e.g., lectins), receptors and ligands. Finally, the field of the invention also encompasses multi-omic MSI procedures, where MSI of photocleavable mass-tag probes is combined with other modes of MSI, such as direct label-free MSI of endogenous biomolecules from the biospecimen (e.g., tissue), whereby said biomolecules can be intact or digested (e.g., chemically digested or by enzyme).
Owner:AMBERGEN
A multi-point precise sampling system, method and device for brain tumors
ActiveCN111973154BAccurate locationExact coordinatesSurgical navigation systemsVaccination/ovulation diagnosticsRemoval tumorTumor removal
The present invention relates to a multi-point precise sampling system, method and device for brain tumors. Outline the tumor boundary and obtain MRI data within the tumor boundary; extract MRI data and convert the MRI data into first-order features, second-order features, shape features, and texture features; obtain a 3D topographic map of the cerebral cortex through 3D reconstruction and spatial clustering , realize the classification of tumor subregions; use CT data and MRI data to formulate a navigation plan, calibrate the scope of tumor resection, and obtain the reference coordinates of the tumor boundary and tumor entity, map to the radiomics partition constructed by MRI, and obtain the location of each partition Center position coordinates and fault-tolerant boundary coordinate intervals; import the tumor boundary and the reference coordinates of the tumor entity into the AR device, and remove the tumor focus; import the 3D topographic map and sub-region classification of the cerebral cortex into the laser positioning and material collection device, and use the laser positioning and material collection device Slice layer by layer. Accurate positioning of tumor lesions and sampling.
Owner:SHANDONG UNIV QILU HOSPITAL
Medical catheter structure, use method and purpose
PendingCN111790049ADesign scienceUnique structureOther blood circulation devicesCatheterRemoval tumorBlood flow
The invention belongs to the field of medical devices and equipment, and particularly relates to a medical catheter structure, a purpose and a use method. The medical catheter structure disclosed by the invention mainly comprises a soft thick casing pipe I, a soft thick casing pipe II, connecting ends II, a pipeline blood flow control device and a blood flow detection meter. When a catheter bridging manner is used, tumor tissue, invaded aorta or other artery vessels can be safely and completely excised, the problem that a malignant diseased region is difficult to be subjected to a surgery is solved, and the medical catheter structure can be further widely applied to the field of medical care.
Owner:吴向阳
Negative pressure suction type tumor excision device
PendingCN114533302AEasy to moveImprove stabilityExcision instrumentsInstruments for stereotaxic surgeryRemoval tumorEngineering
The invention discloses a negative pressure suction type tumor resection device which comprises a workbench, a transverse plate, a supporting leg pipe and a negative pressure shield, the workbench is provided with a side baffle, an air cylinder and a reinforcing rib, the transverse plate is provided with a negative pressure pipe, a first handle and a second handle, the first handle is provided with a first switch, the second handle is provided with a second switch, and a sliding rod is arranged on a telescopic rod of the air cylinder. The lower end of the negative pressure pipe is connected with a negative pressure shield, the negative pressure shield is provided with a groove opening, a sealing ring and an observation plate, the supporting leg pipe is provided with a sliding cavity and trundles, an adjusting rod is arranged in the sliding cavity in a sliding and sleeved mode, a sliding partition plate and a reset spring are arranged in the sliding cavity, and a sliding groove is formed in the adjusting rod. The overall stability of tumor negative pressure excision is improved, the phenomenon of infection caused by exposure in the process of negative pressure tumor excision is avoided, the practicability of tumor excision is improved, the situation of the process of negative pressure suction tumor excision is conveniently observed in real time, and the situation that the tumor is collided by foreign objects during negative pressure suction tumor excision is avoided.
Owner:李金帮
Excision extraction device for gynecological uterine cavity tumor resection surgery
PendingCN114052845AClean up thoroughlyQuality improvementIncision instrumentsExcision instrumentsRemoval tumorReoperative surgery
The invention discloses an excision extraction device for gynecological uterine cavity tumor excision surgery, and particularly relates to the technical field of excision extraction devices. The excision extraction device comprises a first shell, a second shell is arranged above the first shell, a third shell is arranged above the second shell, and a cavity is formed in the second shell and the third shell; a through hole is formed in one side of the first shell and communicates with the interior of the first shell, a first extraction mechanism, a suction mechanism and a control box are arranged in the first shell, the first extraction mechanism is arranged on one side of the suction mechanism, and a cutting mechanism is arranged in the cavity. A second extracting mechanism is arranged at the top end of the third shell, and a collecting mechanism is arranged on one side of the first shell. The tumor is extracted in a targeted mode according to the size of the diameter of the tumor cut in an operation, the tumor is thoroughly removed, and the quality and efficiency of the operation are improved.
Owner:PEOPLES HOSPITAL OF ZHENGZHOU
Method for treatment of cholangiocarcinoma with cold atmospheric plasma and folfirinox
PendingUS20210196970A1Low five-year survival rateHigh recurrence rateElectrotherapyAntineoplastic agentsRemoval tumorParanasal Sinus Carcinoma
A method for a method for treatment of cholangiocarcinoma (CCA) with cold atmospheric plasma and Folfirinox. The method includes treating a patient having CCA with a low dosage FOLFIRINOX regimen, for example, 6.73 nM, giving the patient the low-dosage FOLFIRINOX regimen pre-operatively, surgically removing the cancerous tumor from the patient, continuing the low-dosage FOLFIRINOX treatment regimen intra-operatively, applying cold atmospheric plasma to the surgical margins surrounding the area in the patient from which the tumor was removed, and continuing the FOLFIRINOX post-operatively.
Owner:JEROME CANADY RES INST FOR ADVANCED BIOLOGICAL & TECHCAL SCI
Near-infrared-light-sensitive ZIF8 functionalized gelatin nanofiber scaffold system and application thereof
ActiveCN113713169AHas near-infrared light-sensitive propertiesSatisfy the requirements for producing bone defectsPharmaceutical delivery mechanismNanomedicineRemoval tumorNanoparti cles
The invention belongs to the field of tissue engineering scaffold materials and particularly relates to a near-infrared-light-sensitive ZIF8 functionalized gelatin nanofiber scaffold system and application thereof. The ZIF8 functionalized gelatin nanofiber scaffold system comprises a gelatin nanofiber scaffold and ZIF8 nanoparticles which are adsorbed onto the gelatin nanofiber scaffold and are subjected to calcination treatment. The invention finds that the ZIF8 nanoparticles have near-infrared-light-sensitive characteristics after being calcined, and can kill tumor cells under the action of near-infrared light stress. The ZIF8 functionalized gelatin nanofiber scaffold system disclosed by the invention is implanted into a defect part after bone tumor excision, and under the action of NIR, a temperature of a GF / ZIF8-phenamil scaffold is increased, so that residual tumor cells are killed. In practical application, in-situ transplantation can be adopted, the requirements of residual tumor cells and bone defect generation after tumor tissue excision can be met, and a new choice is provided for clinical bone tumor treatment.
Owner:WENZHOU MEDICAL UNIV
Surgical instrument for gastric cancer
PendingCN114631771AHigh precisionImprove work efficiencyLaproscopesEndoscopesRemoval tumorEngineering
The gastric cancer surgical instrument comprises a gastroscope, a laparoscope, intestinal forceps and a resection device, the gastroscope comprises a control panel, a gastroscope illuminating lamp, a gastroscope indicator and a gastroscope camera are installed on the control panel, and an irradiation range changing mechanism matched with the gastroscope illuminating lamp is arranged on the control panel. The intestinal forceps comprise an intestinal forceps frame and two forceps blades connected to the intestinal forceps frame. The tumor excision forceps have the advantages that the manual screw rotates to drive the U-shaped frame to move, so that the two inclined plates are driven to be opened and closed, the forceps blades are driven to be opened and closed, the forceps blades are automatically fixed after being opened and closed, the function of opening width positioning is completed, the operation time is long during tumor excision, a large amount of blood or even fester exudes from diseased tissue, and the operation difficulty is lowered. In the prior art, a soft catheter, a connecting tube and a drainage device are adopted for drainage and suction, so that the working efficiency is improved.
Owner:郭甲民
Backbone prosthesis with supination-type expansion tube structure handle and using method thereof
PendingCN110811930AWithout breaking integrityGood length adaptabilityJoint implantsFemoral headsRemoval tumorFemoral shaft
The invention relates to a backbone prosthesis of a supination-type expansion tube structure handle and a using method thereof, and the using method comprises the following steps: firstly, excising bone tissue of a femur shaft involved by a tumor, screwing a cylindrical end of an expansion bolt into a threaded hole I, and placing a circular cone body of the expansion bolt outside an expansion holeI; screwing the cylindrical end of the other expansion bolt into a threaded hole II, and arranging the circular cone body of the expansion bolt outside the expansion hole II; inserting a handle partI of the near-end part into a backbone medullary cavity at the upper end of a femur, anticlockwise rotating the expansion bolt to enable the circular cone body of the expansion bolt to enter the expansion hole I of the handle part I, and expanding the four blades I to be in close press fit with the bone wall of the medullary cavity; inserting a handle part II of the far-end part into the backbonemedullary cavity at the lower end of the femur, rotating the expansion bolt counterclockwise to enable the circular cone body of the expansion bolt to enter the expansion hole II of the handle part II, and expanding the four blades II to be in close press fit with the bone wall of the medullary cavity; and a reconstruction part I of the near-end part and a reconstruction part II of the far-end part are fixed together. The postoperative immediate three-dimensional stability of the prosthesis handle is achieved.
Owner:胡永成
Multi-point accurate sampling system, method and device for brain tumors
ActiveCN111973154AImprove the discrimination rateAccurate locationSurgical navigation systemsVaccination/ovulation diagnosticsRemoval tumorTumor solid
The invention relates to a multi-point accurate sampling system, method and device for brain tumors. The method comprises the steps of drawing a tumor boundary, and acquiring MRI data in a tumor boundary range; extracting MRI data, and converting the MRI data into a first-order feature, a second-order feature, a shape feature and a texture feature; through three-dimensional reconstruction and spatial clustering, obtaining a cerebral cortex 3D topographic map, and realizing classification of tumor sub-regions; formulating a navigation plan by utilizing the CT data and the MRI data, calibratinga tumor excision range, acquiring reference coordinates of a tumor boundary and a tumor entity, mapping the reference coordinates to an imaging subarea constructed by MRI, and acquiring a central position coordinate and a fault-tolerant boundary coordinate interval of each subarea; importing the reference coordinates of the tumor boundary and the tumor entity into AR equipment, and enabling a tumor focus to be excised; and introducing the cerebral cortex 3D topographic map and the sub-regions into a laser positioning and sampling device in a classified manner, and performing slicing layer by layer by using the laser positioning and sampling device. Accurate positioning and sampling of tumor focuses are realized.
Owner:SHANDONG UNIV QILU HOSPITAL
Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes
PendingUS20220137065A1Avoid cross-reaction of the probes with each otherAvoid artifactsOrganic chemistryMicrobiological testing/measurementRemoval tumorMass spectrometry imaging
The field of this invention relates to immunohistochemistry (IHC) and in situ hybridization (ISH) for the targeted detection and mapping of biomolecules (e.g., proteins and miRNAs) in tissues or cells for example, for research use and for clinical use such by pathologists (e.g., biomarker analyses of a resected tumor or tumor biopsy). In particular, the use of mass spectrometric imaging (MSI) as a mode to detect and map the biomolecules in tissues or cells for example. More specifically, the field of this invention relates to photocleavable mass-tag reagents which are attached to probes such as antibodies and nucleic acids and used to achieve multiplex immunohistochemistry and in situ hybridization, with MSI as the mode of detection / readout. Probe types other than antibodies and nucleic acids are also covered in the field of invention, including but not limited to carbohydrate-binding proteins (e.g., lectins), receptors and ligands. Finally, the field of the invention also encompasses multi-omic MSI procedures, where MSI of photocleavable mass-tag probes is combined with other modes of MSI, such as direct label-free MSI of endogenous biomolecules from the biospecimen (e.g., tissue), whereby said biomolecules can be intact or digested (e.g., chemically digested or by enzyme).
Owner:AMBERGEN INC
Multi-mode laparoscopic surgery device and implementation method
PendingCN112336306AImprove recognition accuracyLow recurrence rateSurgeryDiagnostics using spectroscopyRemoval tumorLaparoscopes
The invention discloses a multi-mode laparoscopic surgery device and an implementation method. The multi-mode laparoscopic surgery device comprises a computer, a hyperspectral imaging system, a photoacoustic imaging system and a laparoscope unit, wherein the computer is used for determining a hyperspectral mode or a photoacoustic imaging mode and sending a control instruction to the hyperspectralimaging system and the photoacoustic imaging system; the hyperspectral imaging system is used for acquiring hyperspectral imaging data according to the control instruction of the computer; the photoacoustic imaging system is used for acquiring photoacoustic imaging data according to the control instruction of the computer; and the laparoscope unit is used for embedding a hyperspectral imaging channel and a photoacoustic imaging channel and guiding completion of abdominal surgery operation according to the hyperspectral imaging data and the photoacoustic imaging data. The multi-mode laparoscopic surgery device improves the recognition accuracy of tumor boundaries in the laparoscopic surgery, can excise tumors to the maximum extent and reduce the recurrence rate under the condition of not damaging adjacent normal tissue, and can be widely applied to the technical field of medical instruments.
Owner:GUANGDONG PROV MEDICAL INSTR INST
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com